Navigation Links
Genta Incorporated Announces First Quarter 2008 Financial Results and Corporate Highlights
Date:5/8/2008

erations;

-- the adequacy of the Company's patents and proprietary rights;

-- the impact of litigation that has been brought against the Company and

its officers and directors and any proposed settlement of such

litigation; and

-- the other risks described under Certain Risks and Uncertainties Related

to the Company's Business, as contained in the Company's Annual Report

on Form 10-K and Quarterly Report on Form 10-Q.

The Company does not undertake to update any forward-looking statements. There are a number of factors that could cause actual results and developments to differ materially. For a discussion of those risks and uncertainties, please see the Company's Annual Report on Form 10-K for 2007 and its most recent quarterly report on Form 10-Q.

CONTACT:

Genta Investor Relations

info@genta.com

Genta Incorporated

Selected Condensed Consolidated Financial Data

(In thousands, except per share data)

(Unaudited)

Three Months Ended

March 31

2008 2007

Product sales - net $117 $94

Cost of goods sold 25 22

Gross margin 92 72

Operating expenses:

Research and development 6,438 3,383

Selling, general and administrative 3,638 4,052

Provision for settlement of

litigation, net (260) (1,560)

Total operating expenses 9,816 5,8
'/>"/>

SOURCE Genta Incorporated
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Genta Announces Presentation of New Clinical and Preclinical Data on Genasense(R) at AACR-NCI-EORTC Targets Conference
2. Syngenta Licenses Chromatin Gene Stacking Technology
3. Genta Completes Appeal of FDA Decision for Genasense(R) in CLL
4. Genta Receives Notice of Non-Compliance with Listing Requirement for NASDAQ Global Market
5. Syngenta and The Royal Society of Chemistry Launch African Science Initiative
6. Genta Incorporated to Present at Lazard Capital Markets 4th Annual Healthcare Conference
7. Genta Receives NASDAQ Non-Compliance Notice
8. Genta Receives Notice of Non-Compliance With NASDAQ Rule
9. Genta Incorporated to Present at the BIO CEO & Investor Conference
10. Genta Announces Common Stock Offering of Approximately $3.1 Million
11. Genta Announces Senior Management Changes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... (PRWEB) January 15, 2014 Cynvenio, a ... management through the genomic analysis of tumor cells in ... Finder™, a web-based cancer decision support application powered by ... with Cynvenio’s ClearID™ genomic test, Therapy Finder will provide ...
(Date:1/15/2014)... A study has been launched to test whether technology ... help to tackle the problem of obesity.  This unique healthcare ... based in Stowmarket) and academics at University Campus Suffolk is ... which is inspired by equipment used to collect data about ...
(Date:1/15/2014)... 2014 DTS Language Services, Inc . ... Portal for Life Science organizations who need document translations. ... matter of their documents in advance with a selection of ... of translations, often a critical factor in clinical and scientific ...
(Date:1/15/2014)... , Jan. 15, 2014 TaiGen Biotechnology Company, Limited ... agreement with R-Pharm, a leading Russian pharmaceutical company, to ... Russian Federation , Turkey ... States (CIS). Nemonoxacin is a novel antibiotic for the treatment ...
Breaking Biology Technology:Cynvenio Offers New Breast Cancer Therapy Finder Application for its ClearID Breast Cancer Genomic Test 2Cynvenio Offers New Breast Cancer Therapy Finder Application for its ClearID Breast Cancer Genomic Test 3Formula 1 Technology Tackles Obesity in Unique Healthcare Partnership 2Formula 1 Technology Tackles Obesity in Unique Healthcare Partnership 3Formula 1 Technology Tackles Obesity in Unique Healthcare Partnership 4DTS Improves Efficiency for Life Science Document Translations 2TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 2TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 3TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 4
... Scott Stevens, Ph.D. , ... Scott Stevens, Ph.D ., assistant professor of molecular ... at Austin,1 University Station, #A4800,2500 Speedway,Austin,TX , ... scott.stevens@mail.utexas.edu. , ...
... By Julia Cino, PhD ... Introduction , ... to manipulate DNA to identify,excise, move and place genes into a variety ... use for many of these recombinant organisms is to produce,proteins. Since many ...
... , , ... , This Application Report ... BioFlo 110,benchtop fermentor/bioreactor system. The modular,BioFlo 110 is offered with ... wide variety of cultures, including mammalian, insect,plant, yeast and bacterial cells. Complete ...
Cached Biology Technology:Fermentation Cell Culture: University Style 2Fermentation Cell Culture: University Style 3Fermentation Cell Culture: University Style 4Fermentation Cell Culture: University Style 5Fermentation Cell Culture: University Style 6Fermentation Cell Culture: University Style 7Fermentation Cell Culture: University Style 8Fermentation Cell Culture: University Style 9High Yield Protein Production from Pichia pastoris Yeast: A Protocol for Benchtop Fermentation 2High Yield Protein Production from Pichia pastoris Yeast: A Protocol for Benchtop Fermentation 3High Yield Protein Production from Pichia pastoris Yeast: A Protocol for Benchtop Fermentation 4High Yield Protein Production from Pichia pastoris Yeast: A Protocol for Benchtop Fermentation 5High Yield Protein Production from Pichia pastoris Yeast: A Protocol for Benchtop Fermentation 6High Yield Protein Production from Pichia pastoris Yeast: A Protocol for Benchtop Fermentation 7High Yield Protein Production from Pichia pastoris Yeast: A Protocol for Benchtop Fermentation 8Hybridoma Cell Culture Application Using a BioFlo 110 Benchtop Bioreactor 2Hybridoma Cell Culture Application Using a BioFlo 110 Benchtop Bioreactor 3Hybridoma Cell Culture Application Using a BioFlo 110 Benchtop Bioreactor 4Hybridoma Cell Culture Application Using a BioFlo 110 Benchtop Bioreactor 5Hybridoma Cell Culture Application Using a BioFlo 110 Benchtop Bioreactor 6
(Date:4/24/2014)... Carbon offsetting initiatives could be improved with new insights ... , Scientists studying the Amazon Basin have revealed ... trees across the region by comparing satellite maps with ... enable researchers to assess more accurately the amount of ... factor in carbon offset schemes, in which trees are ...
(Date:4/23/2014)... analysis of NASA satellite data shows Africa,s Congo rainforest, ... a large-scale decline in greenness over the past decade. ... at Albany, State University of New York, shows between ... of forest area and intensified. The research, published Wednesday ... comprehensive observational studies to explore the effects of long-term ...
(Date:4/23/2014)... from the Indiana University School of Public Health-Bloomington has ... disease by finding a strong association between heme iron, ... disease. , The study found that heme iron consumption ... percent, while no association was found between nonheme iron, ... coronary heart disease. , The study was published online ...
Breaking Biology News(10 mins):Amazon rainforest survey could improve carbon offset schemes 2NASA satellites show drought may take toll on Congo rainforest 2NASA satellites show drought may take toll on Congo rainforest 3Study: Iron consumption can increase risk for heart disease 2
... , NEW YORK (Nov. 3, 2010) -- Scientists at Weill ... better understanding of prostate cancer by uncovering evidence that it ... factors which can be measured and, in the future, destroyed ... research team led by of Dr. Mark A. Rubin, the ...
... and Columbia University Medical Center have been awarded a ... B. Helmsley Charitable Trust, establishing a collaborative program to ... to gain new insight into disease mechanisms and screen ... of immense importance to the future of biomedical research ...
... defects in plants can be predicted based on chromosome ... the addition or deletion of genes and the organization ... involving a Purdue University researcher. The findings identify ... chromosomes, said Brian Dilkes, a Purdue assistant professor of ...
Cached Biology News:Prostate cancer's multiple personalities revealed 2Helmsley Charitable Trust awards more than $15 million to Salk Institute-CUMC 2Helmsley Charitable Trust awards more than $15 million to Salk Institute-CUMC 3Chromosome imbalances lead to predictable plant defects 2
Immunochemistry 1 & 2...
Hucal Agx Antigen Expression Service Specificity: Hucal Agx ...
... The 1-D PAGE ... Kit for Targeted Protein ... SDS PolyAcrylamide Gel Electrophoresis ... chemistry, and cleavable-linker technology ...
Antibody Purification Specificity: Antibody Purification ...
Biology Products: